The idea of identifying Alzheimer’s disease through a blood draw once sounded distant. It is now part of clinical practice, but the headline needs an important second sentence: a blood test does not, by itself, tell the whole story of a person’s memory. In May 2025, the U.S. Food and Drug Administration cleared the first blood test intended to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/β-amyloid 1-42 Plasma Ratio measures two blood markers whose relationsh

When a headline says someone can control a computer with their mind, it can sound like science fiction. The real science is narrower and, in some ways, more moving: researchers are trying to restore everyday choices to people who have lost the ability to speak or move. A brain–computer interface, or BCI, records patterns of brain activity and uses software to translate them into an action, such as moving a cursor or forming words on a screen. Neuralink is one company studying

Last year, Neuro-Reach wrote about why Texas Proposition 14 mattered before voters went to the polls. Now the question has changed. Texans approved the measure in November 2025, authorizing a $3 billion Dementia Prevention and Research Fund and the Dementia Prevention and Research Institute of Texas (DPRIT). What should families expect from that decision? The law gives DPRIT a broad mission. Its research scope includes dementia, Alzheimer’s disease, Parkinson’s disease, and r

This November, Texans have an opportunity to take a historic step toward improving public health and advancing scientific discovery by voting Yes on Proposition 14 . This constitutional amendment would allocate $3 billion over the next decade to establish the Dementia Prevention and Research Institute of Texas (DPRIT) , a groundbreaking initiative designed to fund research, prevention, and care efforts for Alzheimer’s and related neurological diseases. If approved, Propositi

Last weekend, Neuro-Reach hosted an Alzheimer’s and cognitive screening workshop at the Leonel Castillo Community Center , bringing together student volunteers, healthcare professionals, and local residents for a day focused on brain health awareness and early detection . Our team of student volunteers screened more than 50 seniors using a simplified version of the Montreal Cognitive Assessment (MoCA) , a brief and research-based tool used to identify early signs of Alzhei

Researchers have completed the most comprehensive circuit diagram of a mammalian brain fragment ever created. A U.S. team successfully mapped a tiny slice of a mouse's visual cortex, uncovering: 84,000 neurons 500 million synapses 5.4 kilometers of intricate neural wiring This effort represents a monumental leap forward in our ability to understand brain organization — not just in mice, but eventually in humans as well. By comparing healthy vs. diseased neural wiring at such

In a place like Houston, where cutting-edge medicine thrives just a short drive away in the Texas Medical Center, it's easy to assume...

On Sunday, November 10th 2024; Neuro-Reach joined members of Clear Lake First Baptist Church in Houston for a community workshop focused on memory, aging, and the value of recognizing cognitive changes early. The gathering brought brain-health education into a familiar setting where neighbors could ask questions without first having to navigate a specialty clinic. Our student volunteers welcomed participants, helped them check in, and shared printed information on common sign